Working Group 1
Paving the Way for the Future of Standardisation of Biofilm Technologies
WG1 evaluates the advantages and limitations of existing and emerging biofilm methods, guidance, and analysis technologies to determine their suitability as regulatory science tools. It assesses which models, methods, and approaches have the responsiveness, ruggedness, relevance, and reproducibility needed for regulatory use. Its aim is to propose biofilm models and methods that can be considered for standardisation and formally recognised by regulatory bodies.
Objectives
Review and assessment of available methods for biofilm analysis
Evaluation of existing biofilm-forming platforms
Identification of high-applicability methods suitable for regulatory and cross-sector use
Selection of the most relevant biofilm growth models to feed into WG2 discussions and outputs
Engaging with industry e.g. biotechnology companies to explore technologies relevant to biofilm research and regulatory needs
Current Activities
Below is a list of current initiatives WG1 is progressing.
We need your input! If you have relevant expertise, practical experience, informed opinions, or simply the time and willingness to contribute, your involvement will strengthen the quality and impact of our work. The WG is actively working on a number of outputs (below are some examples). If you would like to join and contribute to any of these activities, or if you have suggestions for additional work, please contact one of the WG1 representatives.
Review Articles:
- Biofilm models: A critical user’s guide.
- Introduction to experimental design for antibiofilm interventions.
- Biofilm elimination and regulation.
- Toward a standardized bioinformatics framework for biofilm analysis – State of the art and future perspectives.
Perspective Articles:
- Imaging as analytical method to assess biofilms.
- Bridging the Gap: Standardising Laboratory Biofilm Methods with Applications to the Food Industry for Regulatory Science.
White Papers:
- Biofilms uncovered: A silent global crisis demanding coordinated action.
- Why molecular biofilm data struggle to inform regulation?
- What are the limitations associated with exclusively using viable plate count data for regulatory decision making?
- Spoilage biofilms, economic losses and potential implication for regulatory decisions?
- What guidance is necessary for image analysis to ensure the *** one *** image showed captures the whole story?
- What multiple lines of evidence are needed to support regulatory decision making?
- Vibrational spectroscopic methods for biofilm assessment / analysis.
Achievements
WG1 has over 180 members, who are currently undertaking a wide range of activities, with members contributing substantial effort across multiple strands of work. We will share updates on progress and achievements as they become available.